Found "Health Policies": 1,068 results
Sort by
Sort by
Relevance
Using an experiment among clinical experts to determine the cost and clinical impact of rapid whole exome sequencing in acute pediatric settings
Introduction
Genetic disorders in children contribute to acute hospitalizations and mortality. Early diagnosis is critical for better outcomes but difficult to achieve due to atypical presentations for thousands of potential genetic diseases. Next-generation sequencing (NGS) is a precision
Navigating HTA implementation: a review of Indonesia’s revised HTA guideline
Indonesia issued the 2017 health technology assessment (HTA) guideline to facilitate researchers conducting economic evaluations based on standardised principles. However, our evaluation revealed no significant differences in adherence to its recommendation between HTA studies conducted before and a
The Economic Evaluation of Medical Devices: Challenges (2014)
Pritaporn Kingkaew BPharm, MSc*,
Yot Teerawattananon MD, PhD*
* Health Intervention and Technology Assessment Program (HITAP), Nonthaburi, Thailand
While many of the principles that guide the economic evaluation of medical devices are somewhat similar to those that guide the evaluation of other
Is it Worthwhile to Introduce Pneumococcal Conjugate Vaccine into the Routine Immunization Services?
In Bhutan, respiratory infections are some of the major causes of morbidity and mortality in children. Pneumonia, an infection of the lungs, is among the top 10 common
causes of children’s death in the country. Not only does it impose costs on society that may not be immediately visible (e.g. produ
Providing hearing aids alone is not enough After-provision services must also improve
People with hearing loss who are registered under the Universal Health Coverage scheme areeligible to receive hearing aids from hospitals free-of-charge. However, the costs associated with this policy after having received the hearing aids must still be borne by users such as hearing aid maintenance
English Policy Brief Collection – Volume 1
The English Policy Brief Collection (Volume 1) presents a selection of policy briefs published by the HITAP Foundation. These policy briefs have been categorized under the following key topics:
Chapter 1: Designing Universal Health Coverage (UHC) and Healthcare Systems
Chapter 2: Managing Rare
Value Distribution in New Branded Medicines: How Much Benefits Patients Versus Manufacturers?
Thailand has successfully implemented economic evaluation to inform the inclusion of new, branded medicines within its National List of Essential Medicines (NLEM). This method can be used to assess the health value that new medicines will generate for patients after accounting for the health los
10 / Page